Praveen P. Tipirneni - 14 Jan 2022 Form 4 Insider Report for Morphic Holding, Inc.

Role: President and CEO, Director
Signature: /s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Issuer symbol: N/A
Transactions as of: 14 Jan 2022
Net transactions value: $0
Form type: 4
Filing time: 19 Jan 2022, 18:14:20 UTC
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MORF	Common Stock						4,206	14 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MORF	Stock Option (right to buy Common Stock)	Award	$0	+224,016		$0.000000	224,016	14 Jan 2022	Common Stock	224,016	$44.75	Direct	F2
transaction	MORF	Restricted Stock Units (RSU)	Award	$0	+50,000		$0.000000	50,000	14 Jan 2022	Common Stock	50,000		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 920 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
F2	The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F3	Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F4	The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.